Clinical trial of effects of alogliptin bensoate on endothelial function in type II diabetes mellitus
Not Applicable
- Conditions
- Type II diabetes mellitus
- Registration Number
- JPRN-UMIN000007722
- Lead Sponsor
- Hiroshima University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with cancer Patients with stroke and/or myocardial infarction within 12 weeks of the prior to study Patients with heart failure who have NYHA 4
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method endothelial function, Rho kinase actvity
- Secondary Outcome Measures
Name Time Method